169 related articles for article (PubMed ID: 24657986)
21. Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases.
Hoang MP; Murakata LA; Katabi N; Henson DE; Albores-Saavedra J
Mod Pathol; 2002 Dec; 15(12):1251-8. PubMed ID: 12481004
[TBL] [Abstract][Full Text] [Related]
22. Lymphatic spread differs according to tumor location in extrahepatic bile duct cancer.
Yoshida T; Matsumoto T; Sasaki A; Morii Y; Shibata K; Ishio T; Kitano S
Hepatogastroenterology; 2003; 50(49):17-20. PubMed ID: 12629981
[TBL] [Abstract][Full Text] [Related]
23. Clinical impact of intraoperative histological examination of the ductal resection margin in extrahepatic cholangiocarcinoma.
Konishi M; Iwasaki M; Ochiai A; Hasebe T; Ojima H; Yanagisawa A
Br J Surg; 2010 Sep; 97(9):1363-8. PubMed ID: 20632323
[TBL] [Abstract][Full Text] [Related]
24. Impact of residual in situ carcinoma on postoperative survival in 125 patients with extrahepatic bile duct carcinoma.
Nakanishi Y; Kondo S; Zen Y; Yonemori A; Kubota K; Kawakami H; Tanaka E; Hirano S; Itoh T; Nakanuma Y
J Hepatobiliary Pancreat Sci; 2010 Mar; 17(2):166-73. PubMed ID: 19521656
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Am J Clin Oncol; 2012 Apr; 35(2):136-40. PubMed ID: 21325937
[TBL] [Abstract][Full Text] [Related]
26. Preoperative cholangitis and metastatic lymph node have a negative impact on survival after resection of extrahepatic bile duct cancer.
Cho JY; Han HS; Yoon YS; Hwang DW; Jung K; Kim JH; Kwon Y; Kim H
World J Surg; 2012 Aug; 36(8):1842-7. PubMed ID: 22526039
[TBL] [Abstract][Full Text] [Related]
27. The number of metastatic lymph nodes in extrahepatic bile duct carcinoma as a prognostic factor.
Hong SM; Cho H; Lee OJ; Ro JY
Am J Surg Pathol; 2005 Sep; 29(9):1177-83. PubMed ID: 16096407
[TBL] [Abstract][Full Text] [Related]
28. The mode of lymphatic spread in carcinoma of the bile duct.
Kurosaki I; Tsukada K; Hatakeyama K; Muto T
Am J Surg; 1996 Sep; 172(3):239-43. PubMed ID: 8862075
[TBL] [Abstract][Full Text] [Related]
29. Hepatectomy of segment 4b and 5 with extrahepatic bile duct resection for pT2 gallbladder carcinoma is valid: a single-institution result.
Onoe S; Kaneoka Y; Maeda A; Takayama Y; Fukami Y; Isogai M
Updates Surg; 2015 Sep; 67(3):265-71. PubMed ID: 26286344
[TBL] [Abstract][Full Text] [Related]
30. [Criteria for the resectability of malignant extrahepatic bile duct tumours].
Kissenkoetter S; Witzigmann H
Zentralbl Chir; 2012 Feb; 137(1):32-7. PubMed ID: 22344835
[TBL] [Abstract][Full Text] [Related]
31. Validation of T Stage According to Depth of Invasion and N Stage Subclassification Based on Number of Metastatic Lymph Nodes for Distal Extrahepatic Bile Duct (EBD) Carcinoma.
Moon A; Choi DW; Choi SH; Heo JS; Jang KT
Medicine (Baltimore); 2015 Dec; 94(50):e2064. PubMed ID: 26683915
[TBL] [Abstract][Full Text] [Related]
32. Surgical strategy for T2 and T3 gallbladder cancer: is extrahepatic bile duct resection always necessary?
Choi SB; Han HJ; Kim WB; Song TJ; Suh SO; Choi SY
Langenbecks Arch Surg; 2013 Dec; 398(8):1137-44. PubMed ID: 24057276
[TBL] [Abstract][Full Text] [Related]
33. Endoscopic ultrasonography assessment in preoperative staging for carcinoma of ampulla of Vater and extrahepatic bile duct.
Zhang Q; Nian W; Zhang L; Liang J
Chin Med J (Engl); 1996 Aug; 109(8):622-5. PubMed ID: 9206064
[TBL] [Abstract][Full Text] [Related]
34. Neuroendocrine carcinoma of the extrahepatic bile duct: case report and literature review.
Sasatomi E; Nalesnik MA; Marsh JW
World J Gastroenterol; 2013 Jul; 19(28):4616-23. PubMed ID: 23901240
[TBL] [Abstract][Full Text] [Related]
35. Pathological appraisal of lines of resection for bile duct carcinoma.
Ebata T; Watanabe H; Ajioka Y; Oda K; Nimura Y
Br J Surg; 2002 Oct; 89(10):1260-7. PubMed ID: 12296893
[TBL] [Abstract][Full Text] [Related]
36. Benefits and limitations of middle bile duct segmental resection for extrahepatic cholangiocarcinoma.
Akita M; Ajiki T; Ueno K; Tsugawa D; Tanaka M; Kido M; Toyama H; Fukumoto T
Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):147-152. PubMed ID: 32037277
[TBL] [Abstract][Full Text] [Related]
37. A case report of primary neuroendocrine carcinoma of the perihilar bile duct.
Kihara Y; Yokomizo H; Urata T; Nagamine M; Hirata T
BMC Surg; 2015 Dec; 15():125. PubMed ID: 26652845
[TBL] [Abstract][Full Text] [Related]
38. Impact of intrapancreatic or extrapancreatic bile duct involvement on survival following pancreatoduodenectomy for common bile duct cancer.
Kamposioras K; Anthoney A; Fernández Moro C; Cairns A; Smith AM; Liaskos C; Verbeke CS
Br J Surg; 2014 Jan; 101(2):89-99. PubMed ID: 24375301
[TBL] [Abstract][Full Text] [Related]
39. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma.
Ito K; Ito H; Allen PJ; Gonen M; Klimstra D; D'Angelica MI; Fong Y; DeMatteo RP; Brennan MF; Blumgart LH; Jarnagin WR
Ann Surg; 2010 Apr; 251(4):675-81. PubMed ID: 20224368
[TBL] [Abstract][Full Text] [Related]
40. [Technique, risks and results of additional portal vein resection in surgical therapy of proximal bile duct carcinoma].
Lorf T; Hanack U; Sattler B; Canelo R; Ringe B
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1335-7. PubMed ID: 9931874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
